» Articles » PMID: 23787892

No Excess of Mitochondrial DNA Deletions Within Muscle in Progressive Multiple Sclerosis

Overview
Journal Mult Scler
Publisher Sage Publications
Specialty Neurology
Date 2013 Jun 22
PMID 23787892
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Mitochondrial dysfunction is an established feature of multiple sclerosis (MS). We recently described high levels of mitochondrial DNA (mtDNA) deletions within respiratory enzyme-deficient (lacking mitochondrial respiratory chain complex IV with intact complex II) neurons and choroid plexus epithelial cells in progressive MS.

Objectives: The objective of this paper is to determine whether respiratory enzyme deficiency and mtDNA deletions in MS were in excess of age-related changes within muscle, which, like neurons, are post-mitotic cells that frequently harbour mtDNA deletions with ageing and in disease.

Methods: In progressive MS cases (n=17), known to harbour an excess of mtDNA deletions in the central nervous system (CNS), and controls (n=15), we studied muscle (paraspinal) and explored mitochondria in single fibres. Histochemistry, immunohistochemistry, laser microdissection, real-time polymerase chain reaction (PCR), long-range PCR and sequencing were used to resolve the single muscle fibres.

Results: The percentage of respiratory enzyme-deficient muscle fibres, mtDNA deletion level and percentage of muscle fibres harbouring high levels of mtDNA deletions were not significantly different in MS compared with controls.

Conclusion: Our findings do not provide support to the existence of a diffuse mitochondrial abnormality involving multiple systems in MS. Understanding the cause(s) of the CNS mitochondrial dysfunction in progressive MS remains a research priority.

Citing Articles

Age-related decline in cerebral oxygen consumption in multiple sclerosis.

Knudsen M, Vestergaard M, Lindberg U, Simonsen H, Frederiksen J, Cramer S J Cereb Blood Flow Metab. 2024; 44(6):1039-1052.

PMID: 38190981 PMC: 11318400. DOI: 10.1177/0271678X231224502.


Enhanced axonal response of mitochondria to demyelination offers neuroprotection: implications for multiple sclerosis.

Licht-Mayer S, Campbell G, Canizares M, Mehta A, Gane A, McGill K Acta Neuropathol. 2020; 140(2):143-167.

PMID: 32572598 PMC: 7360646. DOI: 10.1007/s00401-020-02179-x.


Recent advances in understanding multiple sclerosis.

Stys P, Tsutsui S F1000Res. 2019; 8.

PMID: 31885862 PMC: 6915812. DOI: 10.12688/f1000research.20906.1.


Blood Mononuclear Cell Mitochondrial Respiratory Chain Complex IV Activity Is Decreased in Multiple Sclerosis Patients: Effects of β-Interferon Treatment.

Hargreaves I, Mody N, Land J, Heales S J Clin Med. 2018; 7(2).

PMID: 29461488 PMC: 5852452. DOI: 10.3390/jcm7020036.


Neurodegeneration in Progressive Multiple Sclerosis.

Campbell G, Mahad D Cold Spring Harb Perspect Med. 2018; 8(10).

PMID: 29440322 PMC: 6169982. DOI: 10.1101/cshperspect.a028985.


References
1.
Johnson M, Bindoff L, Turnbull D . Cytochrome c oxidase activity in single muscle fibers: assay techniques and diagnostic applications. Ann Neurol. 1993; 33(1):28-35. DOI: 10.1002/ana.410330106. View

2.
Campbell G, Reeve A, Ziabreva I, Polvikoski T, Taylor R, Reynolds R . Mitochondrial DNA deletions and depletion within paraspinal muscles. Neuropathol Appl Neurobiol. 2012; 39(4):377-89. PMC: 4063338. DOI: 10.1111/j.1365-2990.2012.01290.x. View

3.
Yu-Wai-Man P, Lai-Cheong J, Borthwick G, He L, Taylor G, Greaves L . Somatic mitochondrial DNA deletions accumulate to high levels in aging human extraocular muscles. Invest Ophthalmol Vis Sci. 2010; 51(7):3347-53. PMC: 2904001. DOI: 10.1167/iovs.09-4660. View

4.
Patte M, Rouher F, Vernay D, Delaire J, Bacin F . [Proliferative retinal vasculitis and multiple sclerosis: a case report]. J Fr Ophtalmol. 2003; 26(4):381-5. View

5.
McFarland R, Taylor R, Turnbull D . A neurological perspective on mitochondrial disease. Lancet Neurol. 2010; 9(8):829-40. DOI: 10.1016/S1474-4422(10)70116-2. View